
|Videos|February 3, 2016
The Challenge of High Cost Drugs in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.
Advertisement
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Long COVID and Brain Health
2
Recapping 2025 ASHP Midyear: Expanding the Pharmacist’s Role in Patient Care, Technology, and Health System Resilience
3
Expert: Why Cutting Alcohol May Enhance GLP-1 Outcomes in Patients With Obesity and Diabetes Risk
4
Radio Frequency Identification is Revolutionizing Medication Management
5
















